scholarly journals Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report

2021 ◽  
Vol 12 (4) ◽  
pp. 272-281
Author(s):  
Muhammad Imran Butt ◽  
Abdulmohsen Mohammed Khalid Bakhsh ◽  
Quaid Johar Nadri
2021 ◽  
Vol 27 (6) ◽  
pp. S142-S143
Author(s):  
Muhammad Butt ◽  
Abdulmohsen M. Bakhsh ◽  
Quaid J. Nadri

Thyroid ◽  
2002 ◽  
Vol 12 (2) ◽  
pp. 155-161 ◽  
Author(s):  
Michail Plotkin ◽  
Hubertus Hautzel ◽  
Bernd Joachim Krause ◽  
Daniela Schmidt ◽  
Rolf Larisch ◽  
...  

Medicine ◽  
2021 ◽  
Vol 100 (25) ◽  
pp. e26384
Author(s):  
Nikola Besic ◽  
Barbara Vidergar-Kralj ◽  
Katja Zaletel ◽  
Cvetka Grasic-Kuhar

2016 ◽  
Vol 51 (3) ◽  
pp. 256-260 ◽  
Author(s):  
Apichaya Claimon ◽  
Minseok Suh ◽  
Gi Jeong Cheon ◽  
Dong Soo Lee ◽  
E. Edmund Kim ◽  
...  

2018 ◽  
Vol 24 ◽  
pp. 283-284
Author(s):  
Ifeoma Egbuonu ◽  
Nidhi Bansal ◽  
Sadia Ashraf

2017 ◽  
Vol 2017 ◽  
pp. 1-4 ◽  
Author(s):  
Konstantinos Segkos ◽  
Carl Schmidt ◽  
Fadi Nabhan

Hürthle cell thyroid cancer (HCTC) is a less common form of differentiated thyroid cancer. It rarely metastasizes to the liver, and when it does, the metastasis is almost never isolated. Here we report a 62-year-old male with widely invasive Hürthle cell thyroid cancer, who underwent total thyroidectomy and received adjuvant treatment with I-131 with posttreatment scan showing no evidence of metastatic disease. His thyroglobulin however continued to rise after that and eventually an isolated liver metastasis was identified. He underwent laparoscopic microwave ablation of the liver metastasis, with dramatic decline in thyroglobulin and no structural disease identified to date. This case highlights the rare occurrence of isolated liver metastasis from HCTC and also illustrates the utility of thermoablation as an alternative to surgical resection in the treatment of small isolated liver metastases from HCTC.


Sign in / Sign up

Export Citation Format

Share Document